Literature DB >> 7437239

Vascular smooth muscle response to fibrinogen degradation products and 5-hydroxytryptamine: possible role in cerebral vasospasm in man.

C Forster, E T Whalley, J Mohan, J Dutton.   

Abstract

1 Experiments were performed to determine the effects of fibrin(ogen) degradation products on the following in vitro vascular preparations: rabbit aortic strip, rat aortic strip and human basilar arterial strip. 2 Citrated plasma and streptokinase were incubated at 37 degrees C to produce a crude preparation of fibrinogen degradation products and 0.1 ml aliquots were removed at various time intervals. These samples were tested for intrinsic activity and possible interactions with EC50 and threshold concentrations of 5-hydroxytryptamine on the vascular preparations. 3 Enhancement of the responses obtained by both concentrations of 5-hydroxytryptamine was produced by samples taken throughout the streptokinase incubation period, the maximum effect being seen at 90 min. 4 The 90 min incubate produced volume-dependent (25-400 microliters) potentiations of the responses developed in the three vascular preparations to the EC50 and threshold concentrations of 5-hydroxytryptamine. 5 It is suggested that fibrin(ogen) degradation products may be involved in the intense vasoconstriction of the cerebral arteries following subarachnoid haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437239      PMCID: PMC1430078          DOI: 10.1111/j.1365-2125.1980.tb01749.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.

Authors:  V J Marder; N R Shulman; W R Carroll
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

2.  Experimental studies of intracranial arterial spasm using aortic strip assays.

Authors:  R H Wilkins; G K Wilkins; J C Gunnells; G L Odom
Journal:  J Neurosurg       Date:  1967-12       Impact factor: 5.115

3.  Cerebral arterial spasm. 3. In vivo intracisternal production of spasm by serotonin and blood and its reversal by phenoxybenzamine.

Authors:  G S Allen; L H Gold; S N Chou; L A French
Journal:  J Neurosurg       Date:  1974-04       Impact factor: 5.115

4.  Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect.

Authors:  P R Saxena
Journal:  Eur J Pharmacol       Date:  1974-06       Impact factor: 4.432

5.  Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage.

Authors:  D Tovi; I M Nilsson; C A Thulin
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

6.  Experimental vasoconstriction of cerebral arteries by prostaglandins.

Authors:  Y L Yamamoto; W Feindel; L S Wolfe; H Katoh; C P Hodge
Journal:  J Neurosurg       Date:  1972-10       Impact factor: 5.115

7.  The pharmacological properties of fibrinogen degradation products.

Authors:  K Buluk; M Malofiejew
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

8.  Aneurysm rupture during angiography: does acute vasospasm occur?

Authors:  R H Wilkins
Journal:  Surg Neurol       Date:  1976-05

9.  Cerebral arterial spasm. Part 5: in vitro contractile activity of vasoactive agents including human CSF on human basilar and anterior cerebral arteries.

Authors:  G S Allen; C J Gross; L A French; S N Chou
Journal:  J Neurosurg       Date:  1976-05       Impact factor: 5.115

10.  Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes.

Authors:  L M Starling; D J Boullin; D G Grahame-Smith; C B Adams; R S Gye
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

View more
  3 in total

1.  Analysis of the 5-hydroxytryptamine induced contraction of the human basilar arterial strip compared with the rat aortic strip in vitro.

Authors:  C Forster; E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

2.  The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management.

Authors:  R Towart
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  The effect of subarachnoid erythrocyte lysate on brain injury: a preliminary study.

Authors:  Zi-Huan Zhang; Yan-Ling Han; Chun-Xi Wang; Chen-Hui Zhou; Ling-Yun Wu; Hua-Sheng Zhang; Qiang Chen; Jie-Mei Fan; Meng-Liang Zhou; Chun-Hua Hang
Journal:  Biosci Rep       Date:  2016-07-15       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.